Ascletis Pharma IncAscletis Pharma Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This report of Ascletis Pharma Inc is assembled by All Street Sevva using advanced NLP. Other companies in the rating industry group for Ascletis Pharma Inc are displayedin the table. The webpage contains a Q&A section on Ascletis Pharma Inc.

Ascletis Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 4.8.

SDG Transparency Score for Ascletis Pharma Inc 

3.3

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Ascletis Pharma Inc 
2.0

Environmental

3.2

Social

4.8

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1234Quanterix Corp
3.4
Medium
1234X4 Pharmaceuticals Inc
3.4
Medium
1253Ascletis Pharma Inc
3.3
Medium
1253Calithera Biosciences Inc
3.3
Medium
1253Cara Therapeutics Inc
3.3
Medium
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Ascletis Pharma Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Ascletis Pharma Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Ascletis Pharma Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Ascletis Pharma Inc offer flexible work?

LockedSign up for free to unlock

Does Ascletis Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Ascletis Pharma Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Ascletis Pharma Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose water use targets?

LockedSign up for free to unlock

Does Ascletis Pharma Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Ascletis Pharma Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Ascletis Pharma Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Ascletis Pharma Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Ascletis Pharma Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Ascletis Pharma Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Ascletis Pharma Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose its waste policy?

LockedSign up for free to unlock

Does Ascletis Pharma Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose energy use targets?

LockedSign up for free to unlock

Does Ascletis Pharma Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Ascletis Pharma Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Ascletis Pharma Inc
These potential risks are based on the size, segment and geographies of the company.

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating chronic hepatitis B (CHB) and human immunodeficiency virus functional cure; ASC42 for chronic hepatitis B functional cure; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC, ASC44F FDC, and ASC45F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer; ASC61 and ASC63 for advanced solid tumors; ASC60 to treat solid tumors; and ASC40 for the treatment of acne, Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China.

Sorry!

Failed to process!